ISSX advances research and education on the interplay of living systems with medicines and chemicals.
The International Society for the Study of Xenobiotics (ISSX) is a leading scientific organization dedicated to advancing research and education on the interaction between living systems and medicines and chemicals. With a robust international membership spanning over 50 countries, ISSX plays a crucial role in fostering advancements that benefit society globally.
ISSX serves as a central hub for research scientists from both academia and industry, creating a collaborative environment for professionals and aspiring scientists in toxicology, pharmacology, molecular biology, and related disciplines. Located at 2025 M Street, NW, Suite 800, District of Columbia, Washington 20036, US, ISSX is committed to promoting excellence in the study of xenobiotics.
ISSX continues to expand its reach and impact in the scientific community. This ensures it remains at the forefront of research and education. We invite the manager of the International Society for the Study of Xenobiotics to create a customized and exclusive company showcase and product listing on our platform, allowing you to further highlight your contributions and connect with a wider audience.
Compare International Society for the Study of Xenobiotics with 3 companies in Research-Services
| Comparison Field |
International Society for...Main Company |
American Society for...View Profile |
Altis BiosystemsView Profile |
PharmaronView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1908 | 2015 | 2004 |
|
Company Size
|
— | 11-50 | 11-50 | 10,001+ |
|
City
|
District of Columbia, Washington | Rockville , MD | Durham, NC | |
|
Country
|
United States | |||
|
Skills & Keywords
Comparing with main company
|
12 Total Skills
Xenobiotics
Drug Metabolism
Pharmacology
Toxicology
Molecular Biology
DMPK
Drug-Drug Interactions
Academia & Industry
Professional Networking
International Meetings
Membership Organization
Scientific Research
|
9 Total
9 Unique
Unique Skills:
Behavioral Pharmacology
Cancer Pharmacology
Cardiovascular Pharmacology
Drug Development & Regulatory Affairs
Drug Discovery
Molecular Pharmacology
+3
|
7 Total
7 Unique
Unique Skills:
ADME
Biotechnology
Contract Research
Drug Discovery
Inflammation
Innovation
+1
|
26 Total
26 Unique
Unique Skills:
accelerator mass spectrometry
ADME
analytical sciences
API manufacturing
Assay Development
Biologics
+20
|
Other organizations in the same industry
This company is also known as